Literature DB >> 20686515

Intracisternal or intrathecal glycine, taurine, or muscimol inhibit bicuculline-induced allodynia and thermal hyperalgesia in mice.

Il-ok Lee1, Eui-sung Lim.   

Abstract

AIM: To investigate the effects of GABA and glycine on analgesia in the central nervous system.
METHODS: Glycine, taurine, or muscimol was injected with bicuculline into the cistern magna or the lumbar subarachnoidal space in ICR mice. The effects on bicuculline-induced allodynia in a touch-evoked agitation test and on pain threshold index in a hot-plate test were assessed.
RESULTS: The dosages of the amino acids administered with bicuculline had no effect on motor behavior in conscious mice. Glycine or muscimol reduced bicuculline-induced allodynia regardless of the administration site, whereas intrathecal taurine reduced bicuculline-induced allodynia. Glycine, taurine, and muscimol all antagonized the effects induced by bicuculline in the hot-plate test, regardless of the administration site.
CONCLUSION: Glycine, taurine, and muscimol were found to have anti-allodynic and anti-thermal hyperalgesic properties in vivo. These observations suggest an interaction between glycine and GABA receptors during the regulation of antinociception.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686515      PMCID: PMC4007821          DOI: 10.1038/aps.2010.82

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  27 in total

1.  Taurine activates strychnine-sensitive glycine receptors in neurons of the rat inferior colliculus.

Authors:  Han Xu; Ke-Qing Zhou; Yi-Na Huang; Lin Chen; Tian-Le Xu
Journal:  Brain Res       Date:  2004-09-24       Impact factor: 3.252

2.  Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord.

Authors:  L M Aanonsen; G L Wilcox
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

3.  The gerbil as a model for the study of the epilepsies. Seizure patterns and ontogenesis.

Authors:  W J Loskota; P Lomax; S T Rich
Journal:  Epilepsia       Date:  1974-03       Impact factor: 5.864

4.  Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test.

Authors:  F Porreca; H I Mosberg; J R Omnaas; T F Burks; A Cowan
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

5.  Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist.

Authors:  T Ishikawa; M Marsala; T Sakabe; T L Yaksh
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Antinociceptive effects of baclofen and muscimol upon intraventricular administration.

Authors:  J M Liebman; G Pastor
Journal:  Eur J Pharmacol       Date:  1980-02-08       Impact factor: 4.432

7.  Effects of intrathecally administered THIP, baclofen and muscimol on nociceptive threshold.

Authors:  D L Hammond; E J Drower
Journal:  Eur J Pharmacol       Date:  1984-08-03       Impact factor: 4.432

8.  Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2 alpha in conscious mice.

Authors:  Toshiaki Minami; Isao Nishihara; Seiji Ito; Kazuichi Sakamoto; Masayoshi Hyodo; Osamu Hayaishi
Journal:  Pain       Date:  1995-05       Impact factor: 6.961

9.  Analgesic properties of the GABA-mimetic THIP.

Authors:  R C Hill; R Maurer; H H Buescher; D Roemer
Journal:  Eur J Pharmacol       Date:  1981-01-16       Impact factor: 4.432

10.  Intrathecal morphine in mice: a new technique.

Authors:  J L Hylden; G L Wilcox
Journal:  Eur J Pharmacol       Date:  1980-10-17       Impact factor: 4.432

View more
  9 in total

1.  Inactivation of basolateral amygdala specifically eliminates palatability-related information in cortical sensory responses.

Authors:  Caitlin E Piette; Madelyn A Baez-Santiago; Emily E Reid; Donald B Katz; Anan Moran
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

Review 2.  PKCγ interneurons, a gateway to pathological pain in the dorsal horn.

Authors:  Alain Artola; Daniel Voisin; Radhouane Dallel
Journal:  J Neural Transm (Vienna)       Date:  2020-02-27       Impact factor: 3.575

3.  Serotonin in the solitary tract nucleus shortens the laryngeal chemoreflex in anaesthetized neonatal rats.

Authors:  William T Donnelly; Donald Bartlett; J C Leiter
Journal:  Exp Physiol       Date:  2016-06-12       Impact factor: 2.969

4.  Pharmacology of intracisternal or intrathecal glycine, muscimol, and baclofen in strychnine-induced thermal hyperalgesia of mice.

Authors:  Il Ok Lee; Jin Kook Son; Eui-Sung Lim; Yeon-Soo Kim
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

5.  Loss of central inhibition: implications for behavioral hypersensitivity after contusive spinal cord injury in rats.

Authors:  Yerko A Berrocal; Vania W Almeida; Rocio Puentes; Eric P Knott; Jaclyn F Hechtman; Mary Garland; Damien D Pearse
Journal:  Pain Res Treat       Date:  2014-08-10

6.  Reduced GABAergic neuronal activity in zona incerta causes neuropathic pain in a rat sciatic nerve chronic constriction injury model.

Authors:  Hyeong Cheol Moon; Young Seok Park
Journal:  J Pain Res       Date:  2017-05-11       Impact factor: 3.133

7.  Hippocampal GABA(A) Receptor and Pain Sensitivity during Estrous Cycle in the Rat.

Authors:  Mahnaz Taherianfard; Mahnaz Mosavi
Journal:  Iran J Med Sci       Date:  2011-12

Review 8.  Peripheral afferents and spinal inhibitory system in dynamic and static mechanical allodynia.

Authors:  Jun-Ho La; Jin Mo Chung
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

9.  Enhancing excitatory activity of somatosensory cortex alleviates neuropathic pain through regulating homeostatic plasticity.

Authors:  Wenhui Xiong; Xingjie Ping; Matthew S Ripsch; Grace Santa Cruz Chavez; Heidi Elise Hannon; Kewen Jiang; Chunhui Bao; Vaishnavi Jadhav; Lifang Chen; Zhi Chai; Cungen Ma; Huangan Wu; Jianqiao Feng; Armin Blesch; Fletcher A White; Xiaoming Jin
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.